0000950170-24-094819.txt : 20240809
0000950170-24-094819.hdr.sgml : 20240809
20240809163514
ACCESSION NUMBER: 0000950170-24-094819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240808
FILED AS OF DATE: 20240809
DATE AS OF CHANGE: 20240809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kwon SoYoung
CENTRAL INDEX KEY: 0001864406
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 241193376
MAIL ADDRESS:
STREET 1: APTEVO THERAPEUTICS INC.
STREET 2: 2401 4TH AVENUE, SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
ownership.xml
4
X0508
4
2024-08-08
0001671584
Aptevo Therapeutics Inc.
APVO
0001864406
Kwon SoYoung
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
false
true
false
false
SVP, GC, BD & Corp Affairs
false
Common Stock
2024-08-08
4
M
false
213
A
801
D
Restricted Stock Unit
2024-08-08
4
M
false
213
0
D
Common Stock
213
0
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.
SoYoung Kwon
2024-08-09